{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:57:48Z","timestamp":1790830668699,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05967-6","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:08:09Z","timestamp":1790827689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of ursolic acid-loaded cubosomal nanocarriers: enhanced dissolution, pharmacokinetics, bioavailability, and anticancer activity"],"prefix":"10.1007","author":[{"given":"Amol","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3993-8851","authenticated-orcid":false,"given":"Durgacharan","family":"Bhagwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harinath","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Kumbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"15","key":"5967_CR1","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1039\/D2TB00031H","volume":"10","author":"MAS Abourehab","year":"2022","unstructured":"Abourehab MAS, Ansari MJ, Singh A, Hassan A, Abdelgawad MA, Shrivastav P, Abualsoud BM, Amaral LS, Pramanik S (2022) Cubosomes as an emerging platform for drug delivery: a review of the state of the art. J Mater Chem B 10(15):2781\u20132819","journal-title":"J Mater Chem B"},{"issue":"1","key":"5967_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1248\/cpb.c16-00513","volume":"65","author":"MA Ali","year":"2017","unstructured":"Ali MA, Kataoka N, Ranneh AH, Iwao Y, Noguchi S, Oka T, Itai S (2017) Enhancing the solubility and oral bioavailability of poorly water-soluble drugs using monoolein cubosomes. Chem Pharm Bull 65(1):42\u201348","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"5967_CR3","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1038\/s41598-026-36217-7","volume":"16","author":"M Alsunbul","year":"2026","unstructured":"Alsunbul M, El-Masry TA, El-Bouseary MM et al (2026) Cubosomal nanoparticles of lycopene as a novel platform for enhancement in antioxidant and anticancer properties with a molecular docking study. Sci Rep 16:5941","journal-title":"Sci Rep"},{"issue":"4","key":"5967_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2022","unstructured":"Anand U, Dey A, Chandel AKS, Sanyal R, Mishra A, Pandey DK et al (2022) Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis 10(4):1367\u20131401","journal-title":"Genes Dis"},{"key":"5967_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxrep.2025.101900","volume":"14","author":"R Arulnangai","year":"2025","unstructured":"Arulnangai R, Thabassoom HA, Banu HV, Thirugnanasambandham K, Ganesamoorthy R (2025) Recent developments on ursolic acid and its potential biological applications. Toxicol Rep 14:101900","journal-title":"Toxicol Rep"},{"issue":"12","key":"5967_CR6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1080\/03639045.2018.1508220","volume":"44","author":"H Badie","year":"2018","unstructured":"Badie H, Abbas H (2018) Novel small self-assembled resveratrol-bearing cubosomes and hexosomes: preparation, charachterization, and ex vivo permeation. Drug Dev Ind Pharm 44(12):2013\u20132025","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"5967_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.xphs.2020.10.020","volume":"110","author":"DA Bhagwat","year":"2021","unstructured":"Bhagwat DA, Swami PA, Nadaf SJ, Choudhari PB, Kumbar VM, More HN et al (2021) Capsaicin loaded solid SNEDDS for enhanced bioavailability and anticancer activity: in vitro, in silico and in vivo characterization. J Pharm Sci 110(1):280\u2013291","journal-title":"J Pharm Sci"},{"key":"5967_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126108","volume":"684","author":"AH Bhatt","year":"2025","unstructured":"Bhatt AH, Patel HP, Patel PR, Rathod HG, Hirawala JH, Shaikh PS et al (2025) Cubosomes in non-oral drug delivery: advancing precision therapeutics from bench to bedside. Int J Pharm 684:126108","journal-title":"Int J Pharm"},{"issue":"6","key":"5967_CR9","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s11845-022-02926-x","volume":"191","author":"D Courtney","year":"2022","unstructured":"Courtney D, Davey MG, Moloney BM, Barry MK, Sweeney K, McLaughlin RP et al (2022) Breast cancer recurrence: factors impacting occurrence and survival. Ir J Med Sci 191(6):2501\u20132510","journal-title":"Ir J Med Sci"},{"key":"5967_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s44174-025-00384-4","author":"P Dave","year":"2025","unstructured":"Dave P, Raval B, Dudhat K (2025) Cubosomes: next-generation nanocarriers for versatile drug delivery system for cancer therapy and other applications. Biomed Mater Devices. https:\/\/doi.org\/10.1007\/s44174-025-00384-4","journal-title":"Biomed Mater Devices"},{"issue":"12","key":"5967_CR11","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1007\/s11095-006-9104-4","volume":"23","author":"G Dumortier","year":"2006","unstructured":"Dumortier G, Grossiord JL, Agnely F, Chaumeil JC (2006) A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 23(12):2709\u20132728","journal-title":"Pharm Res"},{"key":"5967_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10847-011-0063-y","volume":"73","author":"S Fontanay","year":"2012","unstructured":"Fontanay S, Kedzierewicz F, Duval RE, Clarot I (2012) Physicochemical and thermodynamic characterization of hydroxy pentacyclic triterpenoic acid\/\u03b2-cyclodextrin inclusion complexes. J Incl Phenom Macrocycl Chem 73:341\u2013347","journal-title":"J Incl Phenom Macrocycl Chem"},{"issue":"6","key":"5967_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2174\/1389200221666210105121532","volume":"22","author":"M Garg","year":"2021","unstructured":"Garg M, Goyal A, Kumari S (2021) An update on the recent advances in cubosome: a novel drug delivery system. Curr Drug Metab 22(6):441\u2013450","journal-title":"Curr Drug Metab"},{"issue":"6","key":"5967_CR14","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.210162","volume":"8","author":"LDM G\u00f3mez-Pulido","year":"2021","unstructured":"G\u00f3mez-Pulido LDM, Gonz\u00e1lez-Cano RC, Dom\u00ednguez E, Heredia A (2021) Structure determination of oleanolic and ursolic acids: a combined density functional theory\/vibrational spectroscopy methodology. R Soc Open Sci 8(6):210162","journal-title":"R Soc Open Sci"},{"key":"5967_CR15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.biopha.2018.09.096","volume":"108","author":"J Iqbal","year":"2018","unstructured":"Iqbal J, Abbasi BA, Ahmad R, Mahmood T, Kanwal S, Ali B et al (2018) Ursolic acid a promising candidate in the therapeutics of breast cancer: current status and future implications. Biomed Pharmacother 108:752\u2013756","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"5967_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4155\/tde-2023-0146","volume":"15","author":"T Kedar","year":"2024","unstructured":"Kedar T, Jalalpure S, Kurangi B (2024) Cubosomal nanoformulation increases in vitro dissolution and anticancer activity of fisetin in A549 lung cancer cells. Ther Deliv 15(5):355\u2013369","journal-title":"Ther Deliv"},{"issue":"16","key":"5967_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165920","volume":"21","author":"V Khwaza","year":"2020","unstructured":"Khwaza V, Oyedeji OO, Aderibigbe BA (2020) Ursolic acid-based derivatives as potential anti-cancer agents: an update. Int J Mol Sci 21(16):5920","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5967_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0378-5173(83)90064-9","volume":"15","author":"RW Korsmeyer","year":"1983","unstructured":"Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15(1):25\u201335","journal-title":"Int J Pharm"},{"key":"5967_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/B978-0-12-813687-4.00012-8","volume-title":"Lipid nanocarriers for drug targeting","author":"M Krsti\u0107","year":"2018","unstructured":"Krsti\u0107 M, Medarevi\u0107 \u0110, \u0110uri\u0161 J, Ibri\u0107 S (2018) Self-nanoemulsifying drug delivery systems (SNEDDS) and self-micro emulsifying drug delivery systems (SMEDDS) as lipid nanocarriers for improving dissolution rate and bioavailability of poorly soluble drugs. In: Grumezescu AM (ed) Lipid nanocarriers for drug targeting. William Andrew Publishing, pp 473\u2013508. https:\/\/doi.org\/10.1016\/B978-0-12-813687-4.00012-8"},{"key":"5967_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jfb13040158","volume":"13","author":"VM Kumbar","year":"2022","unstructured":"Kumbar VM, Muddapur U, Muhsinah AB, Alshehri SA, Alshahrani MM, Almazni IA et al (2022) Curcumin-encapsulated nanomicelles improve cellular uptake and cytotoxicity in cisplatin-resistant human oral cancer cells. J Funct Biomater 13:158","journal-title":"J Funct Biomater"},{"key":"5967_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1208\/s12249-023-02565-0","volume":"24","author":"PS Kumbhar","year":"2023","unstructured":"Kumbhar PS, Manjappa AS, Shah RR et al (2023) Nanostructured lipid carrier\u2013based gel for repurposing simvastatin in localized treatment of breast cancer: formulation design, development and in vitro and in vivo characterization. AAPS PharmSciTech 24:106","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"5967_CR22","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1208\/s12249-009-9292-4","volume":"10","author":"J Lai","year":"2009","unstructured":"Lai J, Chen J, Lu Y, Sun J, Hu F, Yin Z et al (2009) Glyceryl monooleate\/poloxamer 407 cubic nanoparticles as oral drug delivery systems: in vitro evaluation and enhanced oral bioavailability of simvastatin. AAPS PharmSciTech 10(3):960\u2013966","journal-title":"AAPS PharmSciTech"},{"key":"5967_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2023.102684","volume":"50","author":"Y Li","year":"2023","unstructured":"Li Y, Zhao L, Zhao Q, Zhou Y, Zhou L, Song P et al (2023) Ursolic acid nanoparticles for glioblastoma therapy. Nanomedicine 50:102684","journal-title":"Nanomedicine"},{"key":"5967_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2026.148066","volume":"505","author":"L Liu","year":"2026","unstructured":"Liu L, Zhang H, Wang J, Zhou Y, Chen D, Yang Y et al (2026) Ursolic acid nanoemulsion system for inhibition of goji berry black mold caused by Alternaria alternata. Food Chem 505:148066","journal-title":"Food Chem"},{"issue":"4","key":"5967_CR25","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3892\/etm.2017.4965","volume":"14","author":"J Luo","year":"2017","unstructured":"Luo J, Hu YL, Wang H (2017) Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis and suppressing inflammatory responses. Exp Ther Med 14(4):3623\u20133631","journal-title":"Exp Ther Med"},{"issue":"4","key":"5967_CR26","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.3892\/etm.2017.4965","volume":"14","author":"J Luo","year":"2017","unstructured":"Luo J, Hu YL, Wang H (2017) Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, suppressing inflammatory responses via the PI3K\/AKT and NF-\u03baB signaling pathways in vitro. Exp Ther Med 14(4):3623\u20133631","journal-title":"Exp Ther Med"},{"key":"5967_CR27","doi-asserted-by":"publisher","first-page":"1456939","DOI":"10.3389\/fnano.2024.1456939","volume":"6","author":"PD Ly","year":"2024","unstructured":"Ly PD, Ly KN, Phan HL, Nguyen HHT, Duong VA, Nguyen HV (2024) Recent advances in surface decoration of nanoparticles in drug delivery. Front Nanotechnol 6:1456939","journal-title":"Front Nanotechnol"},{"key":"5967_CR28","doi-asserted-by":"publisher","first-page":"122665","DOI":"10.1016\/j.ijpharm.2023.122665","volume":"634","author":"A Makhlouf","year":"2023","unstructured":"Makhlouf A, Elnawawy T (2023) Hair regrowth boosting via minoxidil cubosomes: formulation development, in vivo hair regrowth evaluation, histopathological examination and confocal laser microscopy imaging. Int J Pharm 634:122665. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122665","journal-title":"Int J Pharm"},{"key":"5967_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15112559","volume":"15","author":"M Miastkowska","year":"2023","unstructured":"Miastkowska M, Kulawik-Pi\u00f3ro A, Laso\u0144 E, \u015aliwa K, Malinowska MA, Sikora E et al (2023) Topical formulations based on ursolic acid-loaded nanoemulgel with potential application in psoriasis treatment. Pharmaceutics 15:2559","journal-title":"Pharmaceutics"},{"key":"5967_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.787226","volume":"12","author":"A Miatmoko","year":"2021","unstructured":"Miatmoko A, Mianing EA, Sari R, Hendradi E (2021) Nanoparticles use for delivering ursolic acid in cancer therapy: a scoping review. Front Pharmacol 12:787226","journal-title":"Front Pharmacol"},{"issue":"7","key":"5967_CR31","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.xphs.2021.02.007","volume":"110","author":"AM Mohsen","year":"2021","unstructured":"Mohsen AM, Younis MM, Salama A, Darwish AB (2021) Cubosomes as a potential oral drug delivery system for enhancing the hepatoprotective effect of coenzyme Q10. J Pharm Sci 110(7):2677\u20132686","journal-title":"J Pharm Sci"},{"key":"5967_CR32","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jddst.2018.06.026","volume":"47","author":"SJ Nadaf","year":"2018","unstructured":"Nadaf SJ, Killedar SG (2018) Curcumin nanocochleates: design of experiments, solid state characterization and cytotoxicity against breast cancer. J Drug Deliv Sci Technol 47:337\u2013350","journal-title":"J Drug Deliv Sci Technol"},{"key":"5967_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ijbiomac.2020.11.172","volume":"167","author":"S Nadaf","year":"2021","unstructured":"Nadaf S, Jadhav A, Killedar S (2021) Mung bean porous starch for solubility enhancement of poorly soluble drugs. Int J Biol Macromol 167:345\u2013357","journal-title":"Int J Biol Macromol"},{"key":"5967_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122287","volume":"628","author":"SJ Nadaf","year":"2022","unstructured":"Nadaf SJ, Killedar SG, Kumbar VM, Bhagwat DA, Gurav SS (2022) Pazopanib-laden lipid based nanovesicular delivery with augmented oral bioavailability and therapeutic efficacy against non-small cell lung cancer. Int J Pharm 628:122287","journal-title":"Int J Pharm"},{"key":"5967_CR35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/pharmaceutics12121157","volume":"12","author":"AM Nasr","year":"2020","unstructured":"Nasr AM, Elhady SS, Swidan SA, Badawi NM (2020) Celecoxib loaded in-situ provesicular powder and its in vitro cytotoxic effect for cancer therapy. Pharmaceutics 12:1157","journal-title":"Pharmaceutics"},{"key":"5967_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12247-025-10262-7","volume":"21","author":"A Patil","year":"2026","unstructured":"Patil A, Bhagwat D (2026) Quality by design-driven optimization of caffeic acid cubosomes: a bioavailable nanoplatform for breast cancer treatment. J Pharm Innov 21:27","journal-title":"J Pharm Innov"},{"issue":"2","key":"5967_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.22146\/ijp.28745","volume":"37","author":"HD Patil","year":"2026","unstructured":"Patil HD, Bhagwat DA, Mali SS, Saoji SD, Nawadkar DA, Chikhalwale SA et al (2026) Advancements in cubosomes: a promising platform for targeted anticancer drug delivery. Indonesian J Pharm 37(2):238\u2013256","journal-title":"Indonesian J Pharm"},{"key":"5967_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133366","volume":"274","author":"PL Savekar","year":"2024","unstructured":"Savekar PL, Nadaf SJ, Killedar SG, Kumbar VM, Hoskeri JH, Bhagwat DA et al (2024) Citric acid cross-linked pomegranate peel extract hydrogel film for diabetic wound healing. Int J Biol Macromol 274:133366","journal-title":"Int J Biol Macromol"},{"key":"5967_CR39","doi-asserted-by":"publisher","unstructured":"Sangodkar V, Vaidya M, Ayyanar M, Prabhu S, Nadaf S, Naik A, Gurav N, Kumbhar P, Kharkar P, Gurav S (2026) Biopolymeric chitosan\/ZnO-nanocomposite films from pomegranate peels for sustainable and functional food packaging. Inorg Chem Commun 116200. https:\/\/doi.org\/10.1016\/j.inoche.2026.116200","DOI":"10.1016\/j.inoche.2026.116200"},{"issue":"3","key":"5967_CR40","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.3390\/curroncol30030242","volume":"30","author":"JM Seely","year":"2023","unstructured":"Seely JM (2023) Progress and remaining gaps in early detection and treatment of breast cancer. Curr Oncol 30(3):3201\u20133205","journal-title":"Curr Oncol"},{"key":"5967_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nanoso.2024.101403","volume":"40","author":"K Singh","year":"2024","unstructured":"Singh K, Singhal S, Pahwa S, Sethi VA, Sharma S, Singh P et al (2024) Nanomedicine and drug delivery: applications and challenges. Nano Struct Nano Objects 40:101403","journal-title":"Nano Struct Nano Objects"},{"key":"5967_CR42","volume":"7","author":"P Usapkar","year":"2024","unstructured":"Usapkar P, Saoji S, Jagtap P, Ayyanar M, Kalaskar M, Gurav N et al (2024) QbD-guided phospholipid-tagged boswellic acid naturosomal delivery for rheumatoid arthritis. Int J Pharm x 7:100257","journal-title":"Int J Pharm x"},{"key":"5967_CR43","first-page":"721","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang J, Wu SG (2023) Breast cancer: current therapeutic strategies, challenges and perspectives. Breast Cancer (Dove Med Press) 15:721\u2013730","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"5","key":"5967_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063872","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang J, Liu L, Qiu H, Zhang X, Guo W, Chen W et al (2013) Ursolic acid targets multiple signaling pathways to suppress proliferation and induce apoptosis. PLoS ONE 8(5):e63872","journal-title":"PLoS ONE"},{"issue":"5","key":"5967_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063872","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang J, Liu L, Qiu H, Zhang X, Guo W, Chen W, Tian Y, Fu L, Shi D, Cheng J, Huang W, Deng W (2013) Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells. PLoS ONE 8(5):e63872","journal-title":"PLoS ONE"},{"key":"5967_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2024.100197","volume":"5","author":"V Yadav","year":"2024","unstructured":"Yadav V, Galatage ST, Manjappa AS, Salawi A, Peram MR, Nadaf SJ et al (2024) Green synthesis of silver nanoparticles for treatment of bloodstream infections. Microbe 5:100197","journal-title":"Microbe"},{"issue":"45","key":"5967_CR47","doi-asserted-by":"publisher","first-page":"13388","DOI":"10.1021\/ja026085g","volume":"124","author":"D Yang","year":"2002","unstructured":"Yang D, O\u2019Brien DF, Marder SR (2002) Polymerized bicontinuous cubic nanoparticles (cubosomes) from a reactive monoacylglycerol. J Am Chem Soc 124(45):13388\u201313389","journal-title":"J Am Chem Soc"},{"issue":"3","key":"5967_CR48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","volume":"99","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Xie S et al (2010) PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis. Comput Methods Programs Biomed 99(3):306\u2013314","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"5967_CR49","first-page":"287","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji Y, Liu S, Li J, Wu J, Jin Q et al (2025) Global burden of female breast cancer: estimates and projections based on GLOBOCAN. J Natl Cancer Cent 5(3):287\u2013296","journal-title":"J Natl Cancer Cent"},{"key":"5967_CR50","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/crat.201500034","volume":"50","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Tong HHY, Li L, Shek FLY, Lv Y, Zheng Y (2015) Synthesis, characterization and thermal analysis of ursolic acid solid forms. Cryst Res Technol 50:538\u2013548","journal-title":"Cryst Res Technol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05967-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05967-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05967-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:08:11Z","timestamp":1790827691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05967-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":50,"alternative-id":["5967"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05967-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"30 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Institutional Animal Ethics Committee (IAEC) (REG No. BV\/CPK\/CC SEA\/IAEC\/01\/04\/2025) authorized the experimental methodology.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have seen and approved the submitted version of this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}